| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Phosphoproteins | 21 | 2021 | 206 | 3.690 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 7 | 2017 | 23 | 2.390 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 13 | 2017 | 200 | 1.600 |
Why?
|
| Cell Movement | 9 | 2017 | 655 | 1.520 |
Why?
|
| Apoptosis Regulatory Proteins | 18 | 2021 | 161 | 1.440 |
Why?
|
| Cell Adhesion | 12 | 2021 | 238 | 1.350 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 8 | 2012 | 98 | 1.250 |
Why?
|
| Integrins | 9 | 2017 | 54 | 1.010 |
Why?
|
| Signal Transduction | 16 | 2017 | 2157 | 0.900 |
Why?
|
| Integrin alpha5beta1 | 1 | 2021 | 6 | 0.720 |
Why?
|
| Endosomes | 1 | 2021 | 33 | 0.710 |
Why?
|
| Brain Neoplasms | 2 | 2016 | 140 | 0.680 |
Why?
|
| Endocytosis | 1 | 2021 | 118 | 0.670 |
Why?
|
| Cloning, Molecular | 5 | 2006 | 314 | 0.610 |
Why?
|
| Phosphorylation | 10 | 2017 | 986 | 0.590 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2017 | 28 | 0.550 |
Why?
|
| Serine | 1 | 2017 | 79 | 0.540 |
Why?
|
| Animals | 38 | 2017 | 16992 | 0.540 |
Why?
|
| Sesquiterpenes, Guaiane | 2 | 2016 | 3 | 0.510 |
Why?
|
| Neoplasms | 4 | 2013 | 1377 | 0.500 |
Why?
|
| MAP Kinase Signaling System | 6 | 2012 | 196 | 0.490 |
Why?
|
| Glioblastoma | 2 | 2016 | 74 | 0.480 |
Why?
|
| ras Proteins | 4 | 2012 | 54 | 0.480 |
Why?
|
| Enzyme Activation | 7 | 2017 | 462 | 0.440 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2014 | 165 | 0.430 |
Why?
|
| Cell Line, Tumor | 8 | 2021 | 2676 | 0.420 |
Why?
|
| Antineoplastic Agents | 4 | 2016 | 1019 | 0.400 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2011 | 56 | 0.390 |
Why?
|
| Phospholipase D | 2 | 2011 | 49 | 0.390 |
Why?
|
| Necrosis | 1 | 2012 | 54 | 0.380 |
Why?
|
| CHO Cells | 10 | 2012 | 123 | 0.370 |
Why?
|
| Cricetinae | 10 | 2012 | 241 | 0.370 |
Why?
|
| Protein Binding | 10 | 2012 | 1082 | 0.360 |
Why?
|
| Apoptosis | 8 | 2015 | 1568 | 0.350 |
Why?
|
| Humans | 32 | 2021 | 43102 | 0.350 |
Why?
|
| COS Cells | 6 | 2012 | 68 | 0.340 |
Why?
|
| Neuroblastoma | 1 | 2012 | 136 | 0.340 |
Why?
|
| Carboxylic Ester Hydrolases | 3 | 2017 | 58 | 0.320 |
Why?
|
| Fibronectins | 5 | 2011 | 69 | 0.320 |
Why?
|
| Spatial Behavior | 1 | 2009 | 22 | 0.310 |
Why?
|
| Flow Cytometry | 4 | 2006 | 411 | 0.310 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2010 | 69 | 0.310 |
Why?
|
| Exploratory Behavior | 1 | 2009 | 78 | 0.310 |
Why?
|
| Mitogen-Activated Protein Kinases | 5 | 2003 | 137 | 0.300 |
Why?
|
| Maze Learning | 1 | 2009 | 113 | 0.300 |
Why?
|
| Death Domain Receptor Signaling Adaptor Proteins | 1 | 2009 | 3 | 0.300 |
Why?
|
| Cell Proliferation | 9 | 2017 | 1455 | 0.300 |
Why?
|
| Mice | 14 | 2017 | 6644 | 0.300 |
Why?
|
| Gastrula | 4 | 1996 | 6 | 0.290 |
Why?
|
| Cells | 1 | 2008 | 9 | 0.280 |
Why?
|
| Mice, Knockout | 7 | 2017 | 1035 | 0.270 |
Why?
|
| Molecular Biology | 1 | 2008 | 47 | 0.260 |
Why?
|
| Glioma | 1 | 2008 | 96 | 0.250 |
Why?
|
| Hela Cells | 4 | 2012 | 376 | 0.250 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2008 | 220 | 0.230 |
Why?
|
| Cell Adhesion Molecules | 2 | 2006 | 83 | 0.230 |
Why?
|
| Neoplasm Invasiveness | 3 | 2016 | 290 | 0.230 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2005 | 213 | 0.210 |
Why?
|
| Cell Survival | 6 | 2012 | 945 | 0.210 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2017 | 91 | 0.200 |
Why?
|
| Mitochondrial Proteins | 2 | 2017 | 118 | 0.200 |
Why?
|
| Neoplasm Metastasis | 3 | 2013 | 237 | 0.200 |
Why?
|
| Up-Regulation | 1 | 2006 | 536 | 0.200 |
Why?
|
| Cytoplasm | 3 | 2012 | 154 | 0.190 |
Why?
|
| Transfection | 7 | 2015 | 532 | 0.180 |
Why?
|
| Anxiety | 1 | 2009 | 874 | 0.180 |
Why?
|
| Contractile Proteins | 2 | 2012 | 7 | 0.180 |
Why?
|
| Cricetulus | 3 | 2012 | 82 | 0.180 |
Why?
|
| Microfilament Proteins | 2 | 2012 | 72 | 0.170 |
Why?
|
| Cell Line | 5 | 2015 | 1410 | 0.170 |
Why?
|
| MAP Kinase Kinase Kinase 1 | 1 | 2000 | 2 | 0.170 |
Why?
|
| Xenopus laevis | 3 | 1996 | 73 | 0.160 |
Why?
|
| Mass Spectrometry | 1 | 2021 | 280 | 0.160 |
Why?
|
| Molecular Sequence Data | 8 | 2005 | 1542 | 0.160 |
Why?
|
| Embryonic Induction | 2 | 1996 | 3 | 0.160 |
Why?
|
| Amino Acid Sequence | 7 | 2005 | 1180 | 0.160 |
Why?
|
| Models, Molecular | 4 | 2012 | 876 | 0.160 |
Why?
|
| Proteomics | 1 | 2021 | 378 | 0.150 |
Why?
|
| Muscle Development | 2 | 2017 | 51 | 0.140 |
Why?
|
| Threonine | 1 | 2017 | 24 | 0.140 |
Why?
|
| Carotid Artery Injuries | 1 | 2017 | 5 | 0.140 |
Why?
|
| Molecular Structure | 3 | 2016 | 570 | 0.130 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2017 | 12 | 0.130 |
Why?
|
| Mutation | 4 | 2017 | 1177 | 0.130 |
Why?
|
| Gene Expression Regulation | 3 | 2011 | 1070 | 0.130 |
Why?
|
| Receptors, Somatostatin | 1 | 2016 | 3 | 0.130 |
Why?
|
| Active Transport, Cell Nucleus | 4 | 2011 | 60 | 0.130 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 1996 | 2 | 0.130 |
Why?
|
| RNA Interference | 1 | 2017 | 247 | 0.130 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 4 | 2017 | 105 | 0.130 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2017 | 140 | 0.120 |
Why?
|
| Receptors, Opioid, mu | 1 | 2016 | 52 | 0.120 |
Why?
|
| Substrate Specificity | 2 | 2007 | 219 | 0.120 |
Why?
|
| Diamines | 1 | 2015 | 8 | 0.110 |
Why?
|
| Polycyclic Compounds | 1 | 2015 | 7 | 0.110 |
Why?
|
| Porifera | 1 | 2015 | 16 | 0.110 |
Why?
|
| Sequence Homology, Amino Acid | 4 | 2005 | 267 | 0.110 |
Why?
|
| Ruthenium | 1 | 2014 | 16 | 0.110 |
Why?
|
| Coordination Complexes | 1 | 2014 | 28 | 0.110 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2016 | 1124 | 0.110 |
Why?
|
| Alkaloids | 1 | 2015 | 46 | 0.110 |
Why?
|
| Muscle, Skeletal | 1 | 2017 | 316 | 0.110 |
Why?
|
| Organometallic Compounds | 1 | 2014 | 71 | 0.110 |
Why?
|
| Morphogenesis | 2 | 2009 | 48 | 0.100 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2014 | 34 | 0.100 |
Why?
|
| Gene Deletion | 1 | 2014 | 168 | 0.100 |
Why?
|
| Isoenzymes | 1 | 2013 | 168 | 0.100 |
Why?
|
| raf Kinases | 1 | 2012 | 7 | 0.100 |
Why?
|
| Talin | 1 | 2012 | 3 | 0.100 |
Why?
|
| DNA Primers | 3 | 2010 | 294 | 0.100 |
Why?
|
| Staurosporine | 1 | 2012 | 38 | 0.100 |
Why?
|
| Chloroquine | 1 | 2012 | 19 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 3 | 2017 | 1869 | 0.100 |
Why?
|
| Skin | 1 | 2014 | 187 | 0.090 |
Why?
|
| Cells, Cultured | 3 | 2017 | 1621 | 0.090 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2003 | 296 | 0.090 |
Why?
|
| Oncogene Proteins | 1 | 2012 | 21 | 0.090 |
Why?
|
| Gene Amplification | 1 | 2012 | 23 | 0.090 |
Why?
|
| Skin Neoplasms | 1 | 2014 | 178 | 0.090 |
Why?
|
| Kidney Neoplasms | 1 | 2012 | 80 | 0.090 |
Why?
|
| Gene Library | 2 | 2002 | 62 | 0.090 |
Why?
|
| Oligopeptides | 3 | 1996 | 109 | 0.090 |
Why?
|
| Cell Differentiation | 1 | 2015 | 638 | 0.090 |
Why?
|
| Chromosome Aberrations | 1 | 2012 | 61 | 0.090 |
Why?
|
| Base Sequence | 3 | 2010 | 983 | 0.090 |
Why?
|
| Protein Conformation | 2 | 2011 | 416 | 0.090 |
Why?
|
| RNA, Messenger | 2 | 2012 | 1271 | 0.090 |
Why?
|
| Autophagy | 1 | 2012 | 140 | 0.090 |
Why?
|
| Phospholipase C gamma | 1 | 2011 | 9 | 0.090 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 2014 | 43 | 0.080 |
Why?
|
| Models, Biological | 3 | 2015 | 712 | 0.080 |
Why?
|
| Protease Inhibitors | 1 | 2011 | 54 | 0.080 |
Why?
|
| Mice, Nude | 1 | 2011 | 408 | 0.080 |
Why?
|
| Amino Acids | 1 | 2011 | 148 | 0.080 |
Why?
|
| Jurkat Cells | 1 | 2010 | 87 | 0.080 |
Why?
|
| Calcium | 1 | 2012 | 491 | 0.080 |
Why?
|
| Pain Threshold | 1 | 2009 | 34 | 0.080 |
Why?
|
| Interleukin-2 | 1 | 2010 | 91 | 0.080 |
Why?
|
| Discrimination Learning | 1 | 2009 | 38 | 0.080 |
Why?
|
| Association Learning | 1 | 2009 | 35 | 0.080 |
Why?
|
| Nuclear Proteins | 1 | 2012 | 333 | 0.080 |
Why?
|
| Reactive Oxygen Species | 1 | 2012 | 532 | 0.080 |
Why?
|
| Enzyme Inhibitors | 1 | 2011 | 458 | 0.080 |
Why?
|
| Hand Strength | 1 | 2009 | 40 | 0.080 |
Why?
|
| Prognosis | 1 | 2012 | 861 | 0.070 |
Why?
|
| Kidney | 1 | 2011 | 372 | 0.070 |
Why?
|
| Melanoma | 1 | 2010 | 110 | 0.070 |
Why?
|
| Avoidance Learning | 1 | 2009 | 70 | 0.070 |
Why?
|
| Cell Nucleus | 3 | 2006 | 383 | 0.070 |
Why?
|
| Pain Measurement | 1 | 2009 | 183 | 0.070 |
Why?
|
| Protein Isoforms | 1 | 2009 | 139 | 0.070 |
Why?
|
| Analysis of Variance | 1 | 2009 | 575 | 0.070 |
Why?
|
| Peptides | 1 | 2011 | 372 | 0.070 |
Why?
|
| DNA, Complementary | 3 | 2003 | 196 | 0.070 |
Why?
|
| T-Lymphocytes | 1 | 2010 | 386 | 0.070 |
Why?
|
| Motor Activity | 1 | 2009 | 437 | 0.060 |
Why?
|
| Behavior, Animal | 1 | 2009 | 373 | 0.060 |
Why?
|
| Fear | 1 | 2009 | 272 | 0.060 |
Why?
|
| Protein Kinase C-delta | 1 | 2006 | 17 | 0.060 |
Why?
|
| Cell Division | 2 | 2005 | 311 | 0.060 |
Why?
|
| Activins | 2 | 1996 | 8 | 0.060 |
Why?
|
| Inhibins | 2 | 1996 | 5 | 0.060 |
Why?
|
| Structure-Activity Relationship | 3 | 2016 | 506 | 0.060 |
Why?
|
| Binding Sites | 5 | 2002 | 671 | 0.060 |
Why?
|
| Hyperplasia | 2 | 2017 | 39 | 0.060 |
Why?
|
| Muscle Fibers, Skeletal | 2 | 2017 | 70 | 0.060 |
Why?
|
| Fas-Associated Death Domain Protein | 1 | 2005 | 4 | 0.060 |
Why?
|
| Cell Separation | 2 | 2003 | 94 | 0.060 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2016 | 157 | 0.060 |
Why?
|
| Extracellular Matrix | 1 | 2006 | 131 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 3 | 2017 | 108 | 0.060 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2017 | 300 | 0.050 |
Why?
|
| Ubiquitin | 1 | 2005 | 81 | 0.050 |
Why?
|
| Protein Transport | 1 | 2005 | 296 | 0.050 |
Why?
|
| Astrocytes | 1 | 2006 | 244 | 0.050 |
Why?
|
| Precipitin Tests | 3 | 2001 | 52 | 0.050 |
Why?
|
| 3T3 Cells | 2 | 2001 | 64 | 0.050 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 2 | 2006 | 41 | 0.050 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2003 | 105 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 3 | 2001 | 306 | 0.050 |
Why?
|
| Down-Regulation | 1 | 2005 | 456 | 0.050 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2003 | 196 | 0.050 |
Why?
|
| Caspase 3 | 2 | 2015 | 227 | 0.050 |
Why?
|
| Sequence Alignment | 2 | 2002 | 272 | 0.050 |
Why?
|
| Histones | 1 | 2003 | 197 | 0.040 |
Why?
|
| Transformation, Genetic | 1 | 2001 | 20 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2006 | 704 | 0.040 |
Why?
|
| Time Factors | 4 | 2017 | 1857 | 0.040 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2002 | 127 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2003 | 197 | 0.040 |
Why?
|
| Green Fluorescent Proteins | 3 | 2011 | 209 | 0.040 |
Why?
|
| RNA, Small Interfering | 2 | 2015 | 436 | 0.040 |
Why?
|
| Guanosine Triphosphate | 1 | 2000 | 18 | 0.040 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2000 | 84 | 0.040 |
Why?
|
| Adult | 1 | 2016 | 13872 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 4 | 2003 | 423 | 0.040 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2000 | 166 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 3 | 2010 | 256 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2001 | 611 | 0.040 |
Why?
|
| Mesoderm | 2 | 1996 | 73 | 0.040 |
Why?
|
| Cell Membrane | 2 | 2003 | 403 | 0.040 |
Why?
|
| Tissue Culture Techniques | 1 | 2017 | 36 | 0.030 |
Why?
|
| Carotid Arteries | 1 | 2017 | 36 | 0.030 |
Why?
|
| Saphenous Vein | 1 | 2017 | 23 | 0.030 |
Why?
|
| Sarcolemma | 1 | 2017 | 4 | 0.030 |
Why?
|
| Mice, Inbred mdx | 1 | 2017 | 8 | 0.030 |
Why?
|
| Dystrophin | 1 | 2017 | 20 | 0.030 |
Why?
|
| Antigens, CD | 1 | 1997 | 127 | 0.030 |
Why?
|
| Integrin alpha4beta1 | 1 | 1996 | 5 | 0.030 |
Why?
|
| Pleurodeles | 1 | 1996 | 1 | 0.030 |
Why?
|
| Heparin | 1 | 1996 | 40 | 0.030 |
Why?
|
| Plasmids | 2 | 2011 | 244 | 0.030 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2016 | 67 | 0.030 |
Why?
|
| Biological Availability | 1 | 2016 | 116 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 1997 | 321 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2016 | 260 | 0.030 |
Why?
|
| Myoblasts | 1 | 2015 | 30 | 0.030 |
Why?
|
| Indonesia | 1 | 2015 | 22 | 0.030 |
Why?
|
| Phosphoranes | 1 | 2014 | 3 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2014 | 51 | 0.030 |
Why?
|
| Phenotype | 1 | 2017 | 780 | 0.030 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2015 | 84 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2014 | 158 | 0.030 |
Why?
|
| Solubility | 1 | 2014 | 139 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2015 | 189 | 0.030 |
Why?
|
| Rats | 2 | 2016 | 3735 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2015 | 152 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2010 | 883 | 0.030 |
Why?
|
| Codon | 1 | 2014 | 39 | 0.030 |
Why?
|
| Gene Targeting | 1 | 2014 | 39 | 0.030 |
Why?
|
| Genes, ras | 1 | 2014 | 24 | 0.030 |
Why?
|
| Transcription, Genetic | 2 | 2011 | 592 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 734 | 0.030 |
Why?
|
| Pancreatic Neoplasms | 1 | 2016 | 218 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2014 | 173 | 0.020 |
Why?
|
| Amino Acid Motifs | 2 | 2003 | 97 | 0.020 |
Why?
|
| Luminescent Proteins | 2 | 2003 | 68 | 0.020 |
Why?
|
| Water | 1 | 2014 | 316 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 1596 | 0.020 |
Why?
|
| Matrix Metalloproteinase 12 | 1 | 2011 | 4 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2011 | 9 | 0.020 |
Why?
|
| Two-Hybrid System Techniques | 2 | 2001 | 51 | 0.020 |
Why?
|
| Culture Media, Serum-Free | 1 | 2011 | 44 | 0.020 |
Why?
|
| ets-Domain Protein Elk-1 | 1 | 2011 | 27 | 0.020 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2011 | 28 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2016 | 968 | 0.020 |
Why?
|
| Actins | 1 | 2011 | 164 | 0.020 |
Why?
|
| Male | 1 | 2009 | 23409 | 0.020 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2006 | 21 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2006 | 64 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2006 | 168 | 0.020 |
Why?
|
| Wound Healing | 1 | 2006 | 88 | 0.010 |
Why?
|
| Embryo, Nonmammalian | 2 | 1996 | 59 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2006 | 299 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2003 | 181 | 0.010 |
Why?
|
| Point Mutation | 1 | 2003 | 98 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2003 | 183 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2003 | 186 | 0.010 |
Why?
|
| Ligands | 1 | 2003 | 388 | 0.010 |
Why?
|
| Epitopes | 1 | 2002 | 157 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2002 | 301 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2001 | 150 | 0.010 |
Why?
|
| Biological Transport | 1 | 2000 | 204 | 0.010 |
Why?
|
| Alleles | 1 | 2000 | 352 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2001 | 934 | 0.010 |
Why?
|
| Glucose | 1 | 2000 | 244 | 0.010 |
Why?
|
| Integrin alpha6beta1 | 1 | 1997 | 3 | 0.010 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 1997 | 3 | 0.010 |
Why?
|
| Suppression, Genetic | 1 | 1997 | 6 | 0.010 |
Why?
|
| Genetic Complementation Test | 1 | 1997 | 56 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1997 | 508 | 0.010 |
Why?
|
| Ectoderm | 1 | 1996 | 12 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 1996 | 518 | 0.010 |
Why?
|
| Female | 1 | 2014 | 24698 | 0.010 |
Why?
|
| Blastomeres | 1 | 1993 | 9 | 0.010 |
Why?
|
| Extracellular Space | 1 | 1993 | 36 | 0.010 |
Why?
|
| Alternative Splicing | 1 | 1993 | 94 | 0.010 |
Why?
|